SEI Investments’s Xeris Biopharma Holdings XERS Stock Holding History
Bought
Maintained
Sold
Other funds holding XERS
RA
SEI Investments's XERS Position: Q2 2026 in Review
SEI Investments reduced its Xeris Biopharma Holdings (XERS) stake by 41% in Q2 2026, selling an estimated $1.53M and leaving 339,509 shares worth $2.69M. The position accounts for ﹤0.01% of the portfolio, ranked #1804.
SEI Investments first reported a position in XERS in Q1 2025 and has held it in 6 quarters since. The position peaked at $3.36M in Q1 2026. 240 funds tracked by Wall St. Rank hold XERS as of Q2 2026.
- SEI Investments held 339,509 shares of Xeris Biopharma Holdings worth $2.69M as of Q2 2026.
- SEI Investments sold 239,701 Xeris Biopharma Holdings shares in Q2 2026, an estimated $1.53M.
- Xeris Biopharma Holdings made up ﹤0.01% of SEI Investments's portfolio in Q2 2026, its #1804 holding.
- SEI Investments first reported a position in Xeris Biopharma Holdings in Q1 2025 and has held it in 6 quarters since.
- SEI Investments's Xeris Biopharma Holdings position peaked at $3.36M in Q1 2026.
- 240 funds tracked by Wall St. Rank held Xeris Biopharma Holdings as of Q2 2026.
Based on SEI Investments's 13F filing for Q2 2026, filed 14 Aug 2026.